Shoko Co., Ltd. Began Commercial Production of Pharmaceutical Excipient “Viscomedi” at Its South Korean Plant

TOKYO--(BUSINESS WIRE)--Shoko Co., Ltd. (Head Office: Minato-ku, Tokyo; President & CEO: Kentaro Watanabe; hereinafter “Shoko”), a comprehensive commodity trading firm engaged in three business domains—chemicals, plastics, and metal & ceramics—is pleased to announce that, following the sales framework agreement announced in June 2025 with Hannong Chemicals Inc. (Anyang, Gyeonggi-do, South Korea; hereinafter “Hannong Chemicals”), the manufacturing plant for the new pharmaceutical excipie